We constructed miniaturized autoantigen arrays to perform large-scale multiplex characterization of autoantibody responses directed against structurally diverse autoantigens, using submicroliter ...

LONDON - Oncimmune Holdings PLC (AIM: ONC.L), a company specializing in autoantibody profiling for the pharmaceutical and biotechnology sectors, has announced the scheduling of a General Meeting (GM) ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

A specific autoantibody signature was seen in a subset of people with multiple sclerosis (MS) long before clinical symptoms ...

Looking ahead, Oncimmune forecasts financial 2025 revenue to grow 33% to around GBP4 million. The company expects to reach break-even by financial 2026, driven by its ImmunoINSIGHTS platform and ...